|
業務類別
|
Medical Devices |
|
業務概覽
|
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR. |
| 公司地址
| 305 College Road East, Princeton, NJ, USA, 08540 |
| 電話號碼
| +1 732 329-8885 |
| 傳真號碼
| +1 732 329-8650 |
| 公司網頁
| https://www.cytosorbents.com |
| 員工數量
| 149 |
| Mr. Peter J. Mariani |
Chief Financial Officer and Principal Accounting Officer |
美元 152.02K |
23/04/2025 |
| Dr. Efthymios Nikolaos Deliargyris, M.D. |
Chief Medical Officer |
美元 363.34K |
23/04/2025 |
| Dr. Phillip P. Chan, M.D.,PhD |
Chief Executive Officer and Director |
美元 359.35K |
23/04/2025 |
| Mr. Vincent J. Capponi, M.S. |
President and Chief Operating Officer |
美元 377.52K |
23/04/2025 |
|
|
| Mr. Michael G. Bator |
Chairman of the Board |
23/04/2025 |
| Mr. Alan D. Sobel, C.P.A. |
Independent Director |
23/04/2025 |
| Dr. Phillip P. Chan, M.D.,PhD |
Chief Executive Officer and Director |
23/04/2025 |
| Dr. Edward R. Jones, M.B.A.,M.D. |
Independent Director |
23/04/2025 |
| Ms. Jiny Kim, M.B.A. |
Independent Director |
23/04/2025 |
|
|
|
|
